Close
Close
Treatment Database
Recombinant human insulin receptor monoclonal antibody-N-heparan sulfamidase fusion protein
Trade Name not avaiable
Orphan Indication Mucopolysaccharidosis Type IIIA, Sanfilippo A Syndrome
USA Market Approval
USA Designation Date 12-07-2018
Sponsor ArmaGen, Inc.
26679 Agoura Road, Suite #100
Calabasas, California, 91302
More about Sanfilippo Syndrome
Free Newsletter
Treatment News
Related Videos
by Harish Ravi
3,056 views
by Abidemi Uruejoma
10,317 views